Pub. Date : 1990 Apr
PMID : 2109002
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man. | Epoprostenol | PCNA clamp associated factor | Homo sapiens |
| 2 | We studied the effects of prostacyclin (PGI2) on the airway responses to platelet-activating factor (PAF) in a randomized and crossover study in eight normal subjects. | Epoprostenol | PCNA clamp associated factor | Homo sapiens |
| 3 | We studied the effects of prostacyclin (PGI2) on the airway responses to platelet-activating factor (PAF) in a randomized and crossover study in eight normal subjects. | Epoprostenol | PCNA clamp associated factor | Homo sapiens |
| 4 | We studied the effects of prostacyclin (PGI2) on the airway responses to platelet-activating factor (PAF) in a randomized and crossover study in eight normal subjects. | Epoprostenol | PCNA clamp associated factor | Homo sapiens |
| 5 | We studied the effects of prostacyclin (PGI2) on the airway responses to platelet-activating factor (PAF) in a randomized and crossover study in eight normal subjects. | Epoprostenol | PCNA clamp associated factor | Homo sapiens |
| 6 | Ex vivo platelet aggregation to PAF (10(-9) to 10(-7) mol/L) was significantly inhibited by PGI2. | Epoprostenol | PCNA clamp associated factor | Homo sapiens |
| 7 | Thus, PGI2 does not influence PAF-induced bronchoconstriction in man despite causing marked inhibition of ex vivo PAF-induced platelet aggregation and preventing the fall of neutrophils. | Epoprostenol | PCNA clamp associated factor | Homo sapiens |